Corona Remedies IPO, a ₹655 crore OFS, opened December 8 with a ₹1,008-₹1,062 price band. GMP at ₹290 signals 27% listing gains amid 0.67x Day 1 subscription. Strong anchor backing and chronic therapy focus fuel optimism ahead of December 15 listing.
Key Highlights
IPO Timeline: Opens Dec 8, closes Dec 10; allotment Dec 11, listing Dec 15 on BSE/NSE. Lot size: 14 shares (min ₹14,868 retail investment).
Grey Market Buzz: GMP ₹290 (27.31% over upper band), down from ₹365 peak but above ₹250 threshold, reflecting robust sentiment despite market volatility. [ipowatch]
Subscription Update: 0.67x overall on Day 1 (as of Dec 8); Retail 0.96x, NII 0.84x, Employee 1.48x, QIBs 0x. [chittorgarh]
Financial Edge: Branded formulations leader in women's health (62% revenue), cardio-diabeto; P/E 35.3x fully priced per Anand Rathi—subscribe long-term.
Anchor Strength: ₹195 Cr from SBI MF, HDFC MF, Kotak MF, ICICI Pru, Axis MF—29.73% of issue locked.
Pharma investors eye steady growth in chronic segments. Track live subscription for Day 2 momentum.
Sources: Upstox, Chittorgarh.com, IPOWatch.in, Financial Express